Integrated Diagnostics Holdings plc

Total Valuation

Integrated Diagnostics Holdings plc carries a market capitalization of 345.69M, placing it among publicly traded companies globally. Its enterprise value stands at 9.58B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Integrated Diagnostics Holdings plc currently has 600.00M shares outstanding.

Valuation Ratios

Integrated Diagnostics Holdings plc trades at a trailing price-to-earnings ratio of 10.81. The price-to-sales ratio is 1.86, and the price-to-book ratio stands at 3.06.

Enterprise Valuation

On an enterprise value basis, Integrated Diagnostics Holdings plc trades at an EV/EBITDA multiple of 10.04 and an EV/FCF ratio of 8.19. The EV/Sales ratio of 2.02 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.04 provides insight into valuation relative to core operating earnings.

Financial Position

Integrated Diagnostics Holdings plc maintains a current ratio of 1.59, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.86, indicating elevated leverage, while an interest coverage ratio of 6.37 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Integrated Diagnostics Holdings plc posts a return on equity of 32.94 and a return on invested capital of 15.68.

Taxes

Over the trailing twelve months, Integrated Diagnostics Holdings plc has paid 377.91M in income taxes, reflecting an effective tax rate of 33.88.

Stock Price Statistics

Integrated Diagnostics Holdings plc's stock has gained approximately 85.82813% over the past 52 weeks. The 50-day moving average sits at 0.62, while the 200-day moving average is 0.60.

Income Statement

Over the trailing twelve months, Integrated Diagnostics Holdings plc generated 4.75B in revenue and converted that into 817.28M in net income, yielding earnings per share of 1.23. EBITDA reached 953.71M, while operating income came in at 953.71M.

Balance Sheet

Integrated Diagnostics Holdings plc holds 1.29B in cash and equivalents against 1.27B in total debt, resulting in a net debt position of -703.27M. Total book value stands at 2.88B, with working capital of 1.01B providing operational flexibility.

Cash Flow

Integrated Diagnostics Holdings plc produced 838.97M in operating cash flow over the past twelve months. After subtracting -231.55M in capital expenditures, free cash flow totaled 607.42M - equivalent to 1.01 per share.

Margins

Integrated Diagnostics Holdings plc operates with a gross margin of 37.72, reflecting its pricing power and cost economics. The operating margin of 20.08 and net profit margin of 17.21 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Integrated Diagnostics Holdings plc's most recent stock split took place on December 24, 2020 with a 1:4 split ratio.

Scores

Integrated Diagnostics Holdings plc posts an Altman Z-Score of 3.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.